PCM
SNY icon

Pavaki Capital Management’s Sanofi SNY Stock Holding History

Pavaki Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$853K Hold
20,000
– – 0.3% 62
2026
Q1 		$964K Hold
20,000
– – 0.41% 47
2025
Q4 		$969K Buy
+20,000
New +$991K 0.38% 45

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Pavaki Capital Management's SNY Position: Q2 2026 in Review

Pavaki Capital Management held its Sanofi (SNY) position steady in Q2 2026 at 20,000 shares worth $853K. The position accounts for 0.3% of the portfolio, ranked #62.

Pavaki Capital Management first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $969K in Q4 2025. 679 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Pavaki Capital Management held 20,000 shares of Sanofi worth $853K as of Q2 2026.
  • Pavaki Capital Management left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up 0.3% of Pavaki Capital Management's portfolio in Q2 2026, its #62 holding.
  • Pavaki Capital Management first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Pavaki Capital Management's Sanofi position peaked at $969K in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Pavaki Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.